ENTITY

Cortexyme Inc (CRTX US)

Health Care • United States

Cortexyme, Inc. operates as a biotech company. The Company develops therapeutics and diagnostics for the treatment of alzheimer disease and other neurodegenerative disorders. Cortexyme serves clients in the State of California.

Refresh

Focused

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00